biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > trying to understand?

<< Previous

Bullboard Posts

Next >>

Comment by KayakerBCon Apr 21, 2022 2:08pm

129 Views

Post# 34621145

RE:RE:RE:trying to understand?

There was a time when a deal would move the stock. In Sept 2016, we got the Vaccinex deal. BTI ran up to $2+ prior to the announcement. But here we are 6 years later with deals that didn't go anywhere, or we're still waiting for existing deals to move forward, and still no clinical trial. So just the announcement of a deal no longer generates any excitement. Folks are waaaaaaay too jaded.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?